Artificial Pancreas Device System Market Analysis, Trends, Forecast, 2016 - 2024
The artificial pancreas device system is capable of a near perfect replication of the regulatory functions of glucose of a healthy organic pancreas. These systems generally comprise three forms of devices: an insulin pump or infuser, a constant glucose monitoring system, and a glucometer or any other blood glucose measuring device. The measuring device is necessary to help calibrate the CGM, which can also be done using a computer that can maintain an algorithm to control the CGM using values derived from the blood glucose device. An artificial pancreas device system is usually a closed loop system that follows an automated method of delivering insulin to a patient. It can therefore be completely autonomous and can function without any manual inputs, similar to an organic pancreas.
The rate of innovation is exceedingly high in the global artificial pancreas device system market, primarily owing to the massive and swiftly increasing number of diabetics across the world. The count of diabetic patients is especially high in developed economies, where the presence of strong players in medical devices markets, consistent government backing, and high healthcare expenditure can support a high level of technological innovation. Bodies such as the FDA are showing an increasingly louder support to innovators in the global artificial pancreas device system market as well, due to the constant rise in demand from the growing diabetic and geriatric populations.
Download Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=11234
Global Artificial Pancreas Device System Market: Overview
According to World Health Organization (WHO) estimates, 422 million people were diagnosed with diabetes across the globe in 2014. Diabetes is considered one of the leading causes of death in a majority of developed nations, while it is emerging as a larger issue in developing nations. Effective therapeutic measures are required to keep the blood glucose levels of diabetic patients close to normal. Constant monitoring of blood glucose levels is thus important to lower the risk of hypoglycemic episodes in diabetic patients. This is a key factor fueling the demand for artificial pancreas device systems (APDS). APDS is an innovative device used for monitoring blood glucose level and administering insulin in appropriate doses to people suffering from diabetes.
Increase in the incidence of diabetes has made patient-specific care extremely important. An artificial pancreas device system helps in effectively treating diabetes patients. It is designed as a closed yet continuous loop control system required for insulin infusion. The continuous control is intended to facilitate the daily treatment of diabetic patients, especially in cases where medical personnel are not available round the clock or patients have little knowledge about the ailment.
An APDS, therefore, mimics the glucose regulating functions performed by a healthy pancreas. The system is also used to administer insulin to type 2 diabetes patients. Apart from the constant monitoring of blood glucose levels, the system provides optimum balance between blood glucose and insulin in patients. This prevents the occurrence of other diabetes-related disorders such as cardiac arrest and kidney failure.
The report provides a qualitative and quantitative assessment of the various factors affecting the global APDS market’s growth trajectory. It presents insights into the prevailing market trends and compiles exhaustive information relating to the most lucrative regional markets for APDS. Using industry-leading analytical tools, the report presents the information thus obtained in a logical format.
Global Artificial Pancreas Device System Market: Key Opportunities and Threats
Increase in demand for organ transplant and growing prevalence of pancreatic disorders are expected to drive the global artificial pancreas device system market. Rising incidence of pancreatic cancer and pancreatitis and increasing number of diabetics across the world are also fueling demand for advanced technologies.
The market is gaining impetus from increasing consumption of alcohol and other factors that increase the risk of developing pancreatic disorders. Additionally, prevalence of ailments and medical conditions such as lupus and high triglycerides and gallstones is propelling the market. Furthermore, rising geriatric population with pancreatic disorders and introduction of latest technologies such as software based and wireless systems are expected to boost market growth. However, growing awareness about the side effects of the treatment modality and ineffectiveness of this technology in treating athletic diabetes are likely to hamper market growth.
Global Artificial Pancreas Device System Market: Regional Outlook
Regionally, the global artificial pancreas device system market has been segmented into North America, Asia Pacific, Europe, and Rest of the World. India, Indonesia, China, Pakistan, Japan, and the U.S. are the top countries exhibiting the highest incidence of diabetes. Hence, Asia Pacific and North America have emerged as the most lucrative markets for artificial pancreas device systems.
Pre-Book Full Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=11234<ype=S
In order to study the prevailing competitiveness in the market, the report profiles companies based on their financial overview, strategies adopted, and product portfolio. Some of the leading players in the APDS market are Johnson & Johnson, Pancreum LLC, and JDRF.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Artificial Pancreas Device System Market Analysis, Trends, Forecast, 2016 - 2024 here
News-ID: 906796 • Views: 126
More Releases from Transparency Market Research
Small Hydropower Market is expected to expand at a CAGR of 2.9% during the forec …
Highlights of Small Hydropower Market The global small hydropower market is expected to expand at a CAGR of 2.9% during the forecast period. In terms of installed capacity, the small hydropower market is projected to develop installed capacity as high as 160.13 GW by end of 2027, growing from a net capacity of 124.06 GW in 2018. Read report Overview- https://www.transparencymarketresearch.com/small-hydropower-market.html The domain of renewable energy production ensembles a robust framework for global and
Solar Thermal Fuel Market Evolving Technology, Trends and Industry Analysis : 20 …
Solar Thermal Fuel Market: A practical green energy source Solar thermal fuel is a chemical that can absorb solar radiation, store it for a longer period, and release it. Solar thermal fuels (STFs) store solar energy through light-induced changes in their molecular structure, and release the energy in the form of heat in future, as needed. Read report Overview- https://www.transparencymarketresearch.com/solar-thermal-fuel-market.html Solar thermal fuel works on the principle of artificial photosynthesis. It absorbs sunlight and
Automotive Suspension Parts Market Comprehensive Analysis By 2030
Automotive Suspension Parts Market: Introduction According to the report, the global automotive suspension parts market is projected to surpass ~US$ 13 Bn by 2030, expanding at a CAGR of ~3%, owing to an increase in affordability for vehicles among consumers and transition of people into middle and upper middle income groups. The global automotive suspension parts market is mature; however, developments on improving performance of shock absorbers are still boosting
Coronavirus's Impact On Automotive Camshaft Market
Camshaft Market: Introduction According to the report, the global automotive camshaft market is projected to surpass ~US$ 27 Bn by 2027, expanding at a CAGR of ~3% during the forecast period. Asia Pacific and Latin America are anticipated to witness high growth in vehicle production and subsequently, estimated to boost the camshaft market during the forecast period. Obtain Report Details @ https://www.transparencymarketresearch.com/automotive-camshaft-market.html Expansion of Camshaft Market Increased adoption of double overhead camshaft (DOHC) engines
More Releases for Artificial
Artificial Turf Market – Global Need Assumptions 2025 | Artificial Lawn, Grass …
Global Artificial Turf Market: Snapshot Growth opportunities abound in the global market for artificial turf as residential and commercial property owners increasingly focus on ways of keeping lawns green even during the rising incidences of draughts across the globe. Along with providing an easy way of conserving the water otherwise spent on keeping natural grass alive, artificial grass, or artificial turf as it is often referred to, helps eliminate the need
Artificial Blood Market Development
Artificial Blood Market Potential According to the World Health Organization (WHO), there are around 50,000 stem cell transplantations performed annually worldwide, which include 2,000 cord blood hematopoietic stem cell transplants performed each year. Use of stem cells from cord blood is increasing, as it does not require perfect human leukocyte antigen (HLA) tissue matching, can be used allogenically, and has less incidence of graft v/s host disease. According to the New
Artificial intelligence for industrial microbiology
Munich, Germany, November 23, 2017 - vermicon AG, the specialist for microbiological solutions, is launching the new Scan VIT® system for analysis of microorganisms. It is able to quantify and specifically identify single cells directly and without time-consuming enrichment steps. A fully automated analysis evaluation is provided by the intelligent VIT® Vision software, which is the centerpiece of the new, patented technology. In contrast to conventional rapid test methods, the
Artificial Blood Market
Artificial blood is an artificially developed substitute for red blood cells. For decades, scientists have been trying to develop artificial blood from various sources and through different methods to address the shortage of blood for transfusions. Inadequate number of blood donors and the criticality of blood-type rejection have encouraged researchers to develop artificial blood, thus reducing the dependency on blood donors. Transfusion of red blood cells (RBCs) is a standard
Artificial Blood Market
Artificial blood is an artificially developed substitute for red blood cells. For decades, scientists have been trying to develop artificial blood from various sources and through different methods to address the shortage of blood for transfusions. Inadequate number of blood donors and the criticality of blood-type rejection have encouraged researchers to develop artificial blood, thus reducing the dependency on blood donors. Transfusion of red blood cells (RBCs) is a standard and
Global Artificial Intelligence Market
According to a new report, Global Artificial Intelligence Market (2016-2022), published by KBV Research, the global artificial intelligence market is estimated to reach USD 16,274.0 Million by 2022, at a CAGR of 44.5% from 2016 to 2022. The North America market dominated the Global Artificial Intelligence Market in 2015, and would continue to be a dominant market till 2022; thereby growing at a CAGR of 42.7% during the forecast period.